Psomagen, Inc. (KOSDAQ:950200)

South Korea flag South Korea · Delayed Price · Currency is KRW
4,045.00
+55.00 (1.38%)
Feb 21, 2025, 9:00 AM KST
-19.74%
Market Cap 77.81B
Revenue (ttm) 38.14B
Net Income (ttm) -6.04B
Shares Out 19.24M
EPS (ttm) -345.99
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 13,378
Average Volume 20,017
Open 4,025.00
Previous Close 3,990.00
Day's Range 3,995.00 - 4,055.00
52-Week Range 3,765.00 - 6,700.00
Beta 0.10
RSI 45.96
Earnings Date Mar 21, 2025

About Psomagen

Psomagen, Inc. engages in the provision omics solutions and contract laboratory services. The company’s research services comprises of genomics, a study of gene sequence and expression; epigenomics, a study of epigenetic changes, such as chromatin assembly, histone modification, and DNA-protein interaction in a cell; single-cell analysis, research in suspensions, biological fluids, tissues, or cell populations; metagenomics, a study of genetic material from microorganisms in heterogeneous samples; transcriptomics, a study of RNA and its express... [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2004
Employees 89
Stock Exchange KOSDAQ
Ticker Symbol 950200
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.